| European Case Law Identifier: | ECLI:EP:BA:2018:J000417.20180516 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 16 May 2018 | ||||||||
| Case number: | J 0004/17 | ||||||||
| Application number: | 03781836.6 | ||||||||
| IPC class: | A61K 38/11 A61P 13/00 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Pharmaceutical compositions including low dosages of Desmopressin | ||||||||
| Applicant name: | Reprise Biopharmaceutics, LLC | ||||||||
| Opponent name: | Ferring B.V. | ||||||||
| Board: | 3.1.01 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Stay of proceedings for grant Resumption of proceedings for grant |
||||||||
| Catchwords: |
Rule 14(3) EPC is silent on the reasons for setting a date for resumption of the proceedings for grant. It is thus to be concluded that the legislator let it to practice and jurisprudence to define the circumstances that justify setting a date for resumption on a discretionary basis. Resumption of the proceedings is not limited to cases involving misuse or delaying tactics. The possibility that the EPO sets a date for resumption upon staying the proceedings for grant hints towards a broader construction. However an applicant cannot justify its request for resumption based on the length of the entitlement proceedings where this duration has been significantly caused by the applicant's procedural conduct. |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/j170004eu1.html
Date retrieved: 17 May 2021